Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Mesothelioma × Vorinostat × Clear all

Phase

Phase 3 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Other solid neoplasm 1

Conditions

Lymphoma 6 Lymphoma, Large B-Cell, Diffuse 5 Precursor Cell Lymphoblastic Leukemia-Lymphoma 4 Lymphoma, Non-Hodgkin 4 Glioblastoma 4 Carcinoma, Non-Small-Cell Lung 4 Breast Neoplasms 4 Multiple Myeloma 3 Lymphoma, Follicular 3 Leukemia, Myeloid, Acute 3 Gliosarcoma 3 Small Cell Lung Carcinoma 2 Sarcoma 2 Pancreatic Neoplasms 2 Ovarian Neoplasms 2 Neoplasm Metastasis 2 Myelodysplastic Syndromes 2 Lymphoma, T-Cell, Cutaneous 2 Lymphoma, Mantle-Cell 2 Lymphoma, Large-Cell, Anaplastic 2 Lung Neoplasms 2 Leukemia, Megakaryoblastic, Acute 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Leukemia, Erythroblastic, Acute 2 Immunoblastic Lymphadenopathy 2 Hodgkin Disease 2 Glioma 2 Carcinoma, Renal Cell 2 Brain Neoplasms 2 Astrocytoma 2

Interventions

pembrolizumab 8 Cyclophosphamide 5 Pemetrexed 4 Nivolumab 4 Ipilimumab 4 Carboplatin 4 fludarabine 3 Cisplatin 3 Bevacizumab 2 tremelimumab 1 tocilizumab 1 tazemetostat 1 rebastinib 1 pevonedistat 1 osimertinib 1 milademetan 1 fludarabine phosphate 1 epacadostat 1 durvalumab 1 defactinib 1 atezolizumab 1 aldesleukin 1 Vorinostat 1 Thiostrepton 1 Tablets 1 Plicamycin 1 Pentostatin 1 PM 01183 1 Irinotecan 1 Immunotherapy, Adoptive 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01353482 2012-03-22

MESO-02

University College, London

Phase 1/2 Withdrawn

Other solid neoplasmThoracic

Mesothelioma, Malignant, Mesothelioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡